Turnover—
EBIT margin—
Net result€13k-41.5%
Working capital€58k+33.5%
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of BIOINFO EDITION is 1.1% (low). The 2024 annual accounts show equity of €60k and a net result of €13k. Equity is growing by ~38.9% per year across the filed fiscal years. Its solvency ranks better than 57% of 51 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 3 annual accounts.
Financials
FY 2024
€60k
equity
Turnover—
Net result€13kHealth93/100 · Excellent
See full annual accounts
People & board
No director data processed yet.
To directors Publications
No State Gazette publications linked.
To publications Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsMore than 3 years active
Founded in 2022 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone1.1%
Low
0%0,5%1,5%4%10%≥25%
Young company
+Lower-failure-rate sector
−Higher-failure-rate region
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Uitgeven van tijdschriften58130Uitgeverijen van tijdschriften58140
Primary activity highlighted.
Names & trade names
| Legal nameFR | BIOINFO EDITION |
Registered office
Rue Basse 26
1460 Ittre, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.